Compound 5

3-(3-(1-((14S,20S)-24-amino-14-(3-guanidinopropyl)-20-((4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl)-12,15,18-trioxo-3,6,9-trioxa-13,16,19-triazatetracosyl)-1H-1,2,3-triazol-4-yl)propoxy)-5-(3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy)benzoic acid

From: A biomimetic approach for enhancing the in vivo half-life of peptides